That is totally incorrect: the company has enough money to run a 1,000 person trial but they don't need to run one that large - 750 should be sufficient. If the company uses the GWAS info then perhaps 500 could actually be enough this time.
Anavex is near the 11 year low because there is so much uncertainty. If CM can address the uncertainty issues then that will be very helpful.
Market Data 
Markets 
AI
